Although the incidence of anemia in patients with inflammatory bowel disease (IBD), which comprises ulcerative colitis and Crohn’s disease, has reportedly decreased in the last few decades, it is still the most prevalent extraintestinal complication of IBD. Anemia is an important factor in the overall well-being of IBD patients and frequently does not receive the attention it deserves.
Find this FREE CME activity here:
Using clinical case scenarios in two activities will improve learners’ knowledge and competence regarding the recognition and significance of anemia in adult patients with IBD, the impact of anemia on the quality of life of patients with IBD, the significance of anemia as an indicator of disease activity, anemia care pathways and the benefit of engaging patients with IBD anemia in shared decision-making.
Participants in this CME activity are offered a very unique opportunity to engage in a real-time simulated scenario with a trained Standardized Patient (SP). SPs are trained to simulate the symptoms and characteristics of patients you see in your practice. SP sessions are offered to you through an easy-to-use web conferencing platform at a time that is convenient for you. You will receive a scorecard
assessing your SP session within 24 hours.
Gastroenterologists, internal medicine physicians, family medicine physicians, gastroenterology fellows, NPs, and PAs who are involved in the care and treatment of adult patients with IBD.
Upon completion of the educational activity, participants should be able to:
- Describe the factors that contribute to the development of anemia in adult patients with IBD.
- Identify the signs and symptoms of anemia and describe the impact on adult patients with IBD.
- Assess strategies to treat iron-deficiency anemia and anemia of chronic disease in adult patients with IBD to optimize IBD treatment and improve quality of life.
- Evaluate how an anemia care pathway can be incorporated into practice to improve screening, evaluation, treatment and followup care of anemia in adult patients with IBD.
Continuing Education Credit ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and peerXchange, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
ACCME Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
This activity is supported by an independent educational grant from Pfizer Inc.